
Severity of obstructive sleep apnea in patients was shown to be positively associated with a 3-month depression after ischemic stroke, according to study findings.

Severity of obstructive sleep apnea in patients was shown to be positively associated with a 3-month depression after ischemic stroke, according to study findings.

Quality, as opposed to duration, was suggested as the optimal target for prevention and intervention in sleep health among adolescents, with potential efficacy cited in improving psychological functioning, according to study findings.

Shift workers were found to have a higher incidence of excessive daytime sleepiness compared with patients with obstructive sleep apnea (OSA), according to study findings published this week.

The average sleep recommended for an adolescent is 8 to 10 hours per night, but recent study results show sleep deprivation is a widespread concern among this age group.

Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations.

Compared with patients who have just sleep apnea syndrome (SAS), those with both SAS and restless leg syndrome were shown to exhibit a higher degree of insomnia-specific psychological symptoms, which may indicate the benefit of cognitive behavioral therapy in these populations, according to study findings.

Delayed school start times were shown to increase sleep duration among adolescents and lessen the need for catch-up sleep during the weekend, which may assist in addressing nationwide sleep deficits in these populations.

Compared with conventional methods, novel polysomnography parameters better describe how the severity of oxygen desaturation during sleep affects daytime alertness in patients with obstructive sleep apnea (OSA), according to study findings.

Patients with obstructive sleep apnea–hypopnea syndrome (OSAHS) had significantly higher Alzheimer disease biomarkers in their plasma than those without the condition, which may explain the occurrence of cognitive decline in these populations, according to study findings.

To help ease ventilator shortages resulting from the coronavirus disease 2019 pandemic, researchers at New York University’s Tandon School of Engineering were able to modify continuous positive airway pressure machines, used to treat patients with sleep apnea, into alternatives for mechanical ventilators.

More than a third of healthcare workers responding to the coronavirus disease 2019 (COVID-19) pandemic in China during its peak suffered from insomnia, with those reporting sleeplessness also more likely to feel depressed, anxious, and have stress-based trauma, according to study findings published today.

Employees with either obstructive sleep apnea or excessive daytime sleepiness were shown to be 2 times more likely to be involved in occupational incidents, highlighting the serious safety hazard posed by both conditions.

Ashwagandha root extract, a revered herb of Ayurveda, was associated with improvements in quality of life, sleep quality, and mental alertness in elderly patients, according to study findings.

Theranexus announced this week that its phase 2 trial for THN102 (modafinil/flecainide) in patients with Parkinson disease met its primary efficacy end point of significantly increasing the proportion of patients no longer suffering from excessive daytime sleepiness.

Amid the coronavirus disease 2019 (COVID-19) pandemic, the American Academy of Sleep Medicine (AASM) has issued a position statement on the significance of sufficient sleep, which when impaired has been deemed a possible contributing factor to physician burnout.

The FDA has accepted for filing with priority review Jazz Pharmaceuticals’ new drug application for JZP-258. The investigational medicine targets cataplexy and excessive daytime sleepiness associated with narcolepsy.

In older adults who are cognitively unimpaired, sleep-disordered breathing was found to alter Alzheimer disease–sensitive brain regions, causing greater amyloid deposition and neuronal activity, according to study findings.

In patients with hypertension who are overweight or moderately obese, diuretics were shown to potentially reduce the severity of obstructive sleep apnea, according to study findings.

Men demonstrated higher levels of respiratory events and more periodic limb movements but women had significantly higher levels of sleep-associated complaints across all measures.

Toddlers with reported diminished sleep duration and quality during infancy had a greater likelihood of emotional and behavioral problems, with associations proving strongest for internalizing and dysregulation symptoms, according to study findings.

Improved sleep patterns were linked with potential risk reductions of heart attacks, strokes, and other cardiovascular diseases, with additional associations found in helping women achieve and maintain a healthier body weight, according to preliminary research to be presented at American Heart Association's Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2020.

A new review article shows scientific studies have consistently identified links between sleep problems and health outcomes in patients with type 1 diabetes (T1D). Despite the apparent links, there are no screening recommendations related to sleep in patients with the disease.

Sleep duration among adolescents aged 9 to 11 was shown to influence elements of mental health, including depression, anxiety, impulsive behavior, and cognitive performance, according to study findings.

Drug developers have made significant strides in understanding narcolepsy in recent years. Now, those advances are translating into a robust pipeline of potential new therapies.

In 2019, the US Department of Defense (DoD) and Department of Veterans Affairs (VA) approved clinical practice guidelines regarding management and treatment of chronic insomnia disorder and obstructive sleep apnea in VA and DoD patients. The VA/DoD Evidence-Based Practice Work Group formulated the framework to enable more effective screening, treatment, and managements of these diseases, according to a review published in Annals of Internal Medicine.